Comment on

• Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.

  Mazzanti A, Maragna R, Faragli A, Monteforte N, Bloise R, Memmi M, Novelli V, Baiardi P, Bagnardi V, Etheridge SP, Napolitano C, Priori SG. Mazzanti A, et al. J Am Coll Cardiol. 2016 Mar 8;67(9):1053-1058. doi: 10.1016/j.jacc.2015.12.033. J Am Coll Cardiol. 2016. PMID: 26940925 Free PMC article.
• Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?

  Hameed A. Hameed A. J Am Coll Cardiol. 2017 Jan 17;69(2):248. doi: 10.1016/j.jacc.2016.06.083. J Am Coll Cardiol. 2017. PMID: 28081835 No abstract available.